FDA Adverse Event Other Summary report: N

SYNVISC ONE (HYLAN G-F 20) INJECTION

MDR report key: 2379101 · Received December 13, 2011

Report

Report Number
2246315-2011-00312
Event Type
Other
Date Received
December 13, 2011
Date of Event
January 1, 2011
Report Date
December 7, 2011
Manufacturer
GENZYME BIOSURGERY (RIDGEFIELD)
Product Code
MOZ
PMA / PMN Number
P940015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

MFR'S COMMENT: THE BENEFIT-RISK RELATIONSHIP OF THE PRODUCT IS NOT AFFECTED BY THIS REPORT.

Description of Event or Problem · 1

ONE KNEE PRACTICALLY FROZE [JOINT LOCK]. PAIN WITH WALKING LONG DISTANCES [PAIN]. PAIN IN THE SOFT TISSUE AROUND THE KNEE (KNEE PAINFUL) [ARTHRALGIA]. SWELLING IN RIGHT KNEE [JOINT SWELLING]. RIGHT KNEE EFFUSION [JOINT EFFUSION]. MY CONDITION HAS WORSENED [DEVICE INEFFECTIVE]. CASE DESCRIPTION: SPONTANEOUS REPORT WAS RECEIVED ON (B)(6) 2011, FROM A (B)(6) MALE PT, INITIALS (B)(6), WITH OSTEOARTHRITIS. THE PT'S MEDICAL HISTORY WAS NOT PROVIDED. ON (B)(6) 2011, THE PT INITIATED TREATMENT WITH SYNVISC-ONE (HYLAN G-F 20) 6 ML, ONCE IN BOTH THE KNEES. THE LOT NUMBER WAS NOT PROVIDED. ON AN UNSPECIFIED DATE IN (B)(6) 2011, THE PT'S CONDITION WORSENED. THE PT STATED THAT ONE OF HIS KNEES PRACTICALLY FROZE AND WAS VERY PAINFUL. THE PT EXPERIENCED SWELLING IN HIS RIGHT KNEE AND ALSO EXPERIENCED PAIN WHILE WALKING LONG DISTANCES. IN ADDITION TO THIS, THERE WAS PAIN IN THE SOFT TISSUES AROUND THE KNEE. ON (B)(6) 2011, THE PT WAS SEEN BY HIS HEALTH CARE PROFESSIONAL AND AN UNK AMOUNT OF FLUID WAS REMOVED FROM HIS RIGHT KNEE. HE WAS INJECTED WITH A CORTISONE INJECTION THE SAME DAY. OTHER TREATMENT MEDICATION INCLUDED ASPIRIN (ACETYLSALICYLIC ACID). NO ACTION WAS TAKEN WITH SYNVISC-ONE. THE PT'S OUTCOME FOR ALL THE EVENTS WAS NOT PROVIDED. CONCOMITANT MEDICATIONS WERE NOT PROVIDED. THE INTENSITY FOR ALL THE EVENTS WAS NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SYNVISC ONE (HYLAN G-F 20) INJECTION INTRA-ARTICULAR HYALURONIC ACID MOZ GENZYME BIOSURGERY (RIDGEFIELD) UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 64 YR Required Intervention